Results 131 to 140 of about 5,029 (156)
Some of the next articles are maybe not open access.
Imaging in Juvenile Spondyloarthritis
Current Rheumatology Reports, 2016This review aims to provide an update on the use of imaging in the assessment of juvenile spondyloarthritis (JSpA) disease manifestations.Recent studies have demonstrated superior reliability and specificity of MRI for assessment of sacroiliac joint inflammation compared with radiography.
Pamela F Weiss +2 more
exaly +3 more sources
Juvenile spondyloartrhritis is a group of multifactorial diseases in which a disturbed interplay occurs between the immune system and environmental factors on a predisposing genetic background, which leads to inflammation and structural damage of the target tissue.
Lamot, Lovro, Harjaček, Miroslav
openaire +3 more sources
Advances in Juvenile Spondyloarthritis
Current Rheumatology Reports, 2021To provide an overview of recent studies on pathogenesis, diagnosis, and management of juvenile spondyloarthritis (JSpA).Recent studies show differences in gut microbiome in patients with JSpA in comparison to healthy controls. There is increased recognition of the impact of the innate immune system on disease pathology.
Hemalatha Srinivasalu +2 more
openaire +2 more sources
Update on Juvenile Spondyloarthritis
Pediatrics In Review, 2021Spondyloarthritis (SpA) is a blanket term encompassing entities such as enthesitis-related arthritis, nonradiographic axial SpA, and ankylosing spondylitis. These diseases share many clinical features, including a predilection for inflammation of the entheses and the sacroiliac joints. The nomenclature is based on the evolution of the classification of
Lita, Aeder, Karen B, Onel
openaire +2 more sources
Juvenile-Versus Adult-Onset Spondyloarthritis
Rheumatic Disease Clinics of North America, 2020Pamela F Weiss, Johannes Roth
exaly +2 more sources
Objective: To measure disease activity in children with enthesitis-related arthritis the Juvenile Spondyloarthritis Disease Activity Index (JSpADA) was developed and retrospectively validated.
Abhishek Zanwar +2 more
exaly +2 more sources
Treatment of juvenile spondyloarthritis
Archives of disease in childhood, 2021Juvenile spondyloarthritis (jSpA) represents a spectrum of inflammatory arthritis with strong HLA-B27 association and involvement of enthesis and/or axial skeleton that appears in children and young adults. ILAR classification criteria for enthesitis related arthritis subtype of juvenile idiopathic arthritis, which is undifferentiated form of jSpA ...
Vukić, Vana +3 more
openaire +3 more sources
Treatment of Juvenile Spondyloarthritis: Where We Stand
Pediatric Drugs, 2020Juvenile spondyloarthritis is a subset of juvenile idiopathic arthritis (JIA) with onset in late childhood and adolescence and a strong association with human leukocyte antigen (HLA) B-27 positivity and familial aggregation that has the potential for axial involvement, potentially leading to ankylosing spondylitis.
John M. Bridges, Matthew L. Stoll
openaire +2 more sources
Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies
Expert Opinion on Pharmacotherapy, 2020Spondyloarthropathies (SpA) represent a heterogeneous group of inflammatory arthritides with autoimmune pathogenesis that can affect both adults and children with peculiar features such as enthesitis, sacroiliac joint, and axial involvement. Since juvenile onset of SpA (JSpA) is not well codified by the current juvenile idiopathic arthritis ...
Achille, Marino +3 more
openaire +2 more sources

